“Negative Vaccination” by Specific CD4⁺ T Cell Tolerisation Enhances Virus-Specific Protective Antibody Responses

• Karl S. Lang ,

  *To whom correspondence should be addressed. E-mail: karlslang@gmail.com

  Affiliation Institute of Experimental Immunology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Ahmed N. Hegazy,

  Current address: Deutsches Rheuma-Forschungszentrum Berlin, Germany,

  Affiliation Institute of Experimental Immunology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Philipp A. Lang,

  Affiliation Institute of Experimental Immunology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Bruno Eschli,

  Affiliation Institute of Experimental Immunology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Max Löhning,

  Current address: Experimental Immunology, Department of Rheumatology and Clinical Immunology, Charité–University Medicine Berlin, Berlin, Germany

  Affiliation Institute of Experimental Immunology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Hans Hengartner,

  Affiliation Institute of Experimental Immunology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Rolf M. Zinkernagel,

  Affiliation Institute of Experimental Immunology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Mike Recher

  Current address: Department of Internal Medicine, University Hospital Bruderholz, Bruderholz, Switzerland,

  Affiliation Institute of Experimental Immunology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland

  ⨯